Table 2 Clinical and biochemical characteristics of the general study cohorts

N

928

408

Male,% (n)

27.7% (257)

44.6% (182)

<10⁻⁵

Age, years

32 (18–61)

59 (29–84)

<10⁻⁵

Weight, kg

63 (40–147)

80 (46–135)

<10⁻⁵

Height, cm

165 (140–197)

165 (148–188)

0.154

BMI, kg/m²

23.0 (15.1–54.0)

29.3 (18.2–47.6)

<10⁻⁵

Systolic blood pressure, mm Hg

110 (60–150)

130 (100–220)

<10⁻⁵

Diastolic blood pressure, mm Hg

70 (50–100)

80 (60–130)

<10⁻⁵

Waist circumference, cm

80 (48–180)

94 (60–160)

<10⁻⁵

Hip circumference, cm

-

100 (62–165)

-

Waist/hip ratio

-

0.95 (0.54–1.83)

-

Glucose, mmol/L

4.9 (3.2–7.8)

9.6 (3.6–30.5)

<10⁻⁵

Cholesterol, mmol/L

4.2 (2.0–11.8)

5.2 (2.1–16.7)

<10⁻⁵

Triglycerides, mmol/L

1.0 (0.2–6.5)

1.8 (0.2–17.6)

<10⁻⁵

Low-density lipoproteins, mmol/L

3.88 (1.05–15.5)

4.775 (0.23–8.67)

<10⁻⁵

High-density lipoproteins, mmol/L

1.32 (0.59–2.8)

1.27 (0.6–3.6)

0.001

HbA1c, %

5.4 (4.0–7.3)

7.6 (4.4–16.4)

<10⁻⁵

Insulin, μIU/mL

-

12.10 (0.02–97.0)

-

C-peptide, ng/mL

-

4.20 (0.08–36.30)

-